1. Home
  2. PRHI vs BGLC Comparison

PRHI vs BGLC Comparison

Compare PRHI & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Presurance Holdings Inc.

PRHI

Presurance Holdings Inc.

N/A

Current Price

$0.95

Market Cap

13.3M

Sector

Finance

ML Signal

N/A

Logo BioNexus Gene Lab Corp

BGLC

BioNexus Gene Lab Corp

HOLD

Current Price

$4.12

Market Cap

10.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRHI
BGLC
Founded
2009
2017
Country
United States
Malaysia
Employees
9
N/A
Industry
Property-Casualty Insurers
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.3M
10.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PRHI
BGLC
Price
$0.95
$4.12
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
69.0K
202.4K
Earning Date
11-12-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$44,664,000.00
$9,465,006.00
Revenue This Year
$25.91
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2.21
52 Week Low
$0.42
$2.01
52 Week High
$2.83
$15.60

Technical Indicators

Market Signals
Indicator
PRHI
BGLC
Relative Strength Index (RSI) N/A 37.21
Support Level N/A $4.05
Resistance Level N/A $4.34
Average True Range (ATR) 0.00 0.25
MACD 0.00 0.00
Stochastic Oscillator 0.00 12.36

Price Performance

Historical Comparison
PRHI
BGLC

About PRHI Presurance Holdings Inc.

Presurance Holdings Inc Formerly Conifer Holdings Inc is an insurance holding company. The company markets and services the product offerings of the company through specialty personal insurance business lines. The company offers insurance products in Texas, Illinois, and Indiana for homeowners lines and Nevada and Michigan for other lines. The revenues of the company are derived from premiums earned from insurance operations.

About BGLC BioNexus Gene Lab Corp

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

Share on Social Networks: